Trial Profile
Dose Finding Study in Patients With Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral Oc000459 Dosed At Three Dose Schedules for Twelve Weeks Finding Study In Patients With Mild To Moderate Persistent Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Timapiprant (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 23 Oct 2012 Planned number of patients changed from 480 to 900 as reported by European Clinical Trials Database record
- 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.